Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» eteplirsen
eteplirsen
Experts say Sarepta has a clear edge over BioMarin in Duchenne drug battle
Bizjournals.com
Thu, 11/5/15 - 12:47 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs
Pharmalot
Thu, 10/15/15 - 03:59 pm
FDA
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
Sarepta’s competitor on Duchenne drug could get a two-month head start on sales
Bizjournals.com
Wed, 10/14/15 - 02:23 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biomarin
eteplirsen
drisapersen
Sarepta Therapeutics vs. BioMarin Pharmaceutical: Which Company Will Win the DMD Race?
Motley Fool
Tue, 10/6/15 - 07:13 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
Sarepta's Less-Than-Perfect Data
Motley Fool
Mon, 10/5/15 - 11:56 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta gets creative in bolstering its case for quick eteplirsen approval
Fierce Biotech
Thu, 10/1/15 - 09:24 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Redemption for the drug biz could come next week from Cambridge-based Sarepta
Bizjournals.com
Sun, 09/27/15 - 08:32 pm
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
The Market Swooned, but Sarepta Therapeutics Soared in August
Motley Fool
Sat, 09/5/15 - 11:05 am
Sarepta Therapeutics
eteplirsen
Sarepta snags priority review status to keep pace with BioMarin in DMD race
Fierce Biotech
Wed, 08/26/15 - 09:28 am
Sarepta Therapeutics
priority review
Duchenne Muscular Dystrophy
FDA
eteplirsen
drisapersen
Biomarin
FDA Closing In on November Expert Panel Date for BioMarin, Sarepta Drugs
TheStreet.com
Mon, 07/20/15 - 02:37 pm
FDA
Biomarin
advisory panels
eteplirsen
Sarepta Therapeutics
drisapersen
Duchenne Muscular Dystrophy
Sarepta Therapeutics One Step Closer to Drug Approval
Investopedia
Fri, 07/3/15 - 08:00 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
5 Biotech Stocks On Deck With The FDA
Yahoo/Benzinga
Tue, 06/30/15 - 06:13 pm
FDA
Alnylam
Patisiran
Esperion Therapeutics
ETC-1002
Intercept Pharmaceuticals
obeticholic acid
Sarepta Therapeutics
eteplirsen
Tekmira
TKM-PLK1
Sarepta Submits DMD Drug for FDA Approval Review
TheStreet.com
Mon, 06/29/15 - 10:48 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
FDA Tells Sarepta Therapeutics: Come on Down With Your DMD Drug!
TheStreet.com
Tue, 05/19/15 - 05:02 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
A ‘Strange Back and Forth’ Between Sarepta and the FDA
WSJ Pharmalot
Fri, 10/31/14 - 02:13 pm
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Sarepta timeline delayed on muscular dystrophy drug
CNBC
Mon, 10/27/14 - 08:51 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study
The Chairman's Blog
Mon, 10/13/14 - 04:09 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
CEO Reasserts Control Over Biotech Developer of Muscular Dystrophy Drug
Bloomberg/Businessweek
Fri, 08/1/14 - 09:12 am
Pharma CEOs
Duchenne Muscular Dystrophy
eteplirsen
Chris Garabedian
Stop Squabbling, Mom Tells Troubled Biotech: 'Just Get My Kid the Drug'
Bloomberg/Businessweek
Mon, 07/28/14 - 12:19 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Latest Sarepta Study Update Shows Greater Decline in Walking Ability
TheStreet.com
Thu, 07/10/14 - 08:51 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »